Author:
Cunningham D.,Soukop M.,Stuart J.F.B,Setanoians A.,Gilchrist N.L.,Forrest G.J.,Kaye S.B.
Reference8 articles.
1. Phase-I study of α-1,3,5-triglycidyl-s-trizinetrione (NSC 296934);Dombernowsky;Cancer Chemother Pharmacol,1983
2. Phase-I clinical trial with alpha 1,3,5-triglycidyl-s-triazinetrione (NSC 296934);Piccart;Eur J Cancer Clin Oncol,1981
3. Characterization of the activity of α/β-triglycidylurazol (TGU; NSC 32488): a new antineoplastic compound;Atassi;Eur J Cancer Clin Oncol,1984
4. The analysis and animal pharmacokinetics of 1,2,4-triglycidylurazol using a high pressure liquid chromatographic technique;Welsh;Cancer Chemother Pharmacol,1984
5. Reporting results of cancer treatment;Miller;Cancer,1981
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献